IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome

J Am Heart Assoc. 2014 Jan 21;3(1):e000476. doi: 10.1161/JAHA.113.000476.

Abstract

Background: Development of thoracic aortic aneurysms is the most significant clinical phenotype in patients with Marfan syndrome. An inflammatory response has been described in advanced stages of the disease. Because the hallmark of vascular inflammation is local interleukin-6 (IL-6) secretion, we explored the role of this proinflammatory cytokine in the formation of aortic aneurysms and rupture in hypomorphic fibrillin-deficient mice (mgR/mgR).

Methods and results: MgR/mgR mice developed ascending aortic aneurysms with significant dilation of the ascending aorta by 12 weeks (2.7 ± 0.1 and 1.3 ± 0.1 for mgR/mgR versus wild-type mice, respectively; P<0.001). IL-6 signaling was increased in mgR/mgR aortas measured by increases in IL-6 and SOCS3 mRNA transcripts (P<0.05) and in cytokine secretion of IL-6, MCP-1, and GM-CSF (P<0.05). To investigate the role of IL-6 signaling, we generated mgR homozygous mice with IL-6 deficiency (DKO). The extracellular matrix of mgR/mgR mice showed significant disruption of elastin and the presence of dysregulated collagen deposition in the medial-adventitial border by second harmonic generation multiphoton autofluorescence microscopy. DKO mice exhibited less elastin and collagen degeneration than mgR/mgR mice, which was associated with decreased activity of matrix metalloproteinase-9 and had significantly reduced aortic dilation (1.0 ± 0.1 versus 1.6 ± 0.2 mm change from baseline, DKO versus mgR/mgR, P<0.05) that did not affect rupture and survival.

Conclusion: Activation of IL-6-STAT3 signaling contributes to aneurysmal dilation in mgR/mgR mice through increased MMP-9 activity, aggravating extracellular matrix degradation.

Keywords: Marfan syndrome; extracellular matrix; interleukin‐6; matrix metalloproteinases; mgR; thoracic aortic aneurysms and dissections; vascular inflammation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / metabolism*
  • Aorta / pathology
  • Aortic Aneurysm, Thoracic / etiology*
  • Aortic Aneurysm, Thoracic / genetics
  • Aortic Aneurysm, Thoracic / metabolism
  • Aortic Aneurysm, Thoracic / pathology
  • Aortic Aneurysm, Thoracic / prevention & control
  • Aortic Rupture / etiology
  • Aortic Rupture / metabolism
  • Aortic Rupture / pathology
  • Chemokine CCL2 / metabolism
  • Collagen / metabolism
  • Dilatation, Pathologic
  • Disease Models, Animal
  • Elastin / metabolism
  • Extracellular Matrix / metabolism*
  • Fibrillin-1
  • Fibrillins
  • Granulocyte-Macrophage Colony-Stimulating Factor / metabolism
  • Interleukin-6 / deficiency
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism*
  • Marfan Syndrome / complications*
  • Marfan Syndrome / genetics
  • Marfan Syndrome / metabolism
  • Matrix Metalloproteinase 9 / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microfilament Proteins / deficiency
  • Microfilament Proteins / genetics
  • Microfilament Proteins / metabolism*
  • RNA, Messenger / metabolism
  • STAT3 Transcription Factor / metabolism
  • Severity of Illness Index
  • Signal Transduction
  • Suppressor of Cytokine Signaling 3 Protein
  • Suppressor of Cytokine Signaling Proteins / genetics
  • Suppressor of Cytokine Signaling Proteins / metabolism
  • Time Factors
  • Up-Regulation

Substances

  • Ccl2 protein, mouse
  • Chemokine CCL2
  • Fbn1 protein, mouse
  • Fibrillin-1
  • Fibrillins
  • Interleukin-6
  • Microfilament Proteins
  • RNA, Messenger
  • STAT3 Transcription Factor
  • Socs3 protein, mouse
  • Stat3 protein, mouse
  • Suppressor of Cytokine Signaling 3 Protein
  • Suppressor of Cytokine Signaling Proteins
  • interleukin-6, mouse
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Collagen
  • Elastin
  • Matrix Metalloproteinase 9
  • Mmp9 protein, mouse